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Background: The mitogen-activated protein (MAP)
kinase, ERK2, is a tightly regulated enzyme in the ubiq-
uitous Ras-activated protein kinase cascade. ERK2 is
activated by phosphorylation at two sites, Y185 and
T183, that lie in the phosphorylation lip at the mouth of
the catalytic site. To ascertain the role of these two
residues in securing the low-activity conformation of the
enzymes we have carried out crystallographic analyses and
assays of phosphorylation-site mutants of ERK2.
Results: The crystal structures of four mutants, T183E
(threonine at residue 183 is replaced by glutamate),
Y185E, Y185F and the double mutant T183E/Y185E,
were determined. When T183 is replaced by glutamate,
few conformational changes are observed. By contrast,
when Y185 is replaced by glutamate, 19 residues become
disordered, including the entire phosphorylation lip and
an adjacent loop. The conservative substitution of
phenylalanine for Y185 also induces relatively large con-
formational changes. A binding site for phosphotyrosine
in the active enzyme is putatively identified on the basis
of the high-resolution refinement of the structure of
wild-type ERK2.
Conclusions: The remarkable disorder observed through-
out the phosphorylation lip when Y185 is mutated shows
that the stability of the phosphorylation lip is rather low.
Therefore, only modest amounts of binding energy will be
required to dislodge the lip for phosphorylation, and it is
likely that these residues will be involved in conforma-
tional changes associated both with binding to kinases and
phosphatases and with activation. Furthermore, the low-
activity structure is specifically dependent on Y185,
whereas there is no such dependency on T183. Both
residues, however, participate in forming the active
enzyme, contributing to its tight control.
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Introduction
The mitogen-activated protein (MAP) kinase, ERK2
(extracellular signal-regulated kinase 2), is an important
transducer of information from the cell surface to intra-
cellular targets [1-5]. The activity of ERK2 is tightly
regulated. Dual phosphorylation events, one on residue
Y185 and one on T183 are required for ERK2 activation
[2,6,7]. Both of the phosphorylation reactions are cat-
alyzed [8] by the same kinase, MEK (MAP/ERK kinase)
[9,10], although the phosphorylation of Y185 is pre-
ferred kinetically [11]. Inactivation of ERK2 is achieved
independently through the action of serine/threonine
phosphatases, tyrosine phosphatases [2,12], or dual-speci-
ficity phosphatases [13,14], demonstrating that both cova-
lently bound phosphates are required to maintain high
activity. Thus, while a single type of enzyme (MEK) acti-
vates the MAP kinases, multiple pathways may lead to
their inactivation.
We have previously determined the structure of unphos-
phorylated, low-activity ERK2 [15]. The phosphoryla-
tion sites Y185 and T183 are in the phosphorylation lip
(between subdomains VII and VIII), a 15-residue surface
loop near the mouth of the active site (Fig. 1). In
unphosphorylated ERK2, Y185 is found largely buried,
whereas T183 is on the surface. The sequence of this lip
is hypervariable among the protein kinases [16]. Likewise,
the structure of this region varies greatly among the pro-
tein kinases for which structures are available [17]. Based
on the following observations, the phosphorylation lip
probably adopts a considerably different conformation in
the active form of the enzyme [15]. First, in the low-
activity structure, the lip blocks the substrate-binding site.
Second, the residues that form the phosphate-binding
site for T197 in cyclic AMP dependent protein kinase
(cAPK) are conserved in ERK2 [15], yet in unphospho-
rylated ERK2, neither of the phosphorylation site
residues is close enough to interact with this site. Inter-
action of a phospho-amino acid with this site may be
important in promoting the closed-domain configuration
observed in cAPK [18]. Finally, as Y185 is buried, the
phosphorylation lip must assume a different conforma-
tion when bound to MEK.
Several ERK2 mutants have previously been synthesized
and characterized to help in understanding the roles of
the individual phosphorylation sites in the activation of
the enzyme [10]. The published results most relevant to
the present study are that the mutant T183E can be
phosphorylated and partially activated by MEK, whereas
the Y185F mutant can be phosphorylated by MEK but is
not active. Here we describe the enzymatic properties of
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Fig. 2. The phosphorylation lip region drawn in INSIGHT.
Regions that are disordered in the mutants are colored as follows:
the phosphorylation lip is yellow, residues S200-Y203 in
loop199-205 are purple, and E251-1254 in L14 are brown. 13-
strands are shown in green and a-helices are shown in dark blue
with other regions in lighter blue. The carbon atoms of hydro-
phobic residues are colored green and those of polar or charged
residues are colored purple. A sulfate ion is shown as red and
yellow spheres. Hydrogen bonds are shown as dashed lines.
partially substitute for phosphothreonine to form the
active enzyme once Y185 is phosphorylated, but gluta-
mate mimics phosphotyrosine only poorly in the active
structure. Furthermore, glycine does not substitute for
Y185, showing that phosphotyrosine is required to form
the active enzyme.
Fig. 1. Ribbon diagram of ERK2 drawn by Molscript [34]. (a)
Standard kinase view; (b) view 45° rotation about the vertical
axis. The disordered regions in the mutant Y185E or the double
mutant T183E/Y185E are shown in black; the lip and
loopl99-205 are defined by residues 173-197 and 202-203,
respectively. The 'C loop' is the catalytic loop, subdomain VI.
The 'P loop' is the phosphate-binding site for ATP. The nomen-
clature used is based on the secondary-structure elements
assigned in [18]. Intervening sequences, or linkers, are labeled L
based on the terminology in [171, starting at L0, at the N-terminal
extension from the core kinase domain. A few short helices that
are not assigned in [118], are labelled here as linkers. a2L12 refers
to the second helix in L12, etc.
the additional mutant enzymes Y185E, T183E/Y185E,
and T183E/Y185G. The data show that glutamate can
To explore how Y185 of the wild-type enzyme might
become available for phosphorylation by MEK, and to
understand the roles of the phosphorylation-site residues
in the activation of the molecule, we have determined the
structures of four of these ERK2 mutants in the unphos-
phorylated state. The structures of these mutants do not
give us a detailed picture of the active conformation of the
molecule. Instead, the crystallographic analysis shows that
the stability of the phosphorylation lip is low, and suggests
which residues may be involved in conformational
changes associated with activation. In addition, on the
basis of the refinement of the wild-type enzyme structure,
an anchoring site for phosphotyrosine on the surface of
the active enzyme is proposed. Together, the activity and
crystallographic data reveal essential functions for Y185 in
both the inactive and active states of the protein kinase.
Results
Anatomy of the phosphorylation lip of unphosphorylated
wild-type ERK2
The ERK2 phosphorylation sites, T183 and Y185, are in
the lip (Figs 1,2,3) that links subdomains VII and VIII as
defined by Hanks et al. [16]. The lip is part of L12, the
linker between the secondary-structure elements 39 and
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Fig. 3. Stereodiagram emphasizing the
interaction between the lip and loopl 99-
205 region.
F-helix (nomenclature defined in [17], and in Fig. 1
legend). In ERK2, the lip consists of 15 residues, D173-
A187 (DPDHDHTGFLTEYVA) and is near the mouth
of the active site. The side chain of T183 is found on the
surface of the molecule, whereas the side chain of Y185
is largely buried.
Much of the structure of the lip is lost in the mutants
described below. Yet, the structure of the lip in wild-type
ERK2 is well defined (see electron density in Fig. 4a). In
wild-type ERK2, the B-factors for the main-chain atoms
in the lip range from 27 A2-45 A2 , slightly higher than
the average B-factor for the remainder of the C-terminal
domain, which is 22 A2. The residues that flank the
phosphorylation sites, L182, E184, and V186, have B-
factors of over 50 A2, as is obvious from the weak elec-
tron density on these residues (Fig. 4a).
The lip makes an unusual interaction with a neighboring
loop, which comprises residues N199-K205 (labeled
loop199-205 in Fig. la,b). The lip and loop199-205 form
a semi-compact structure (Fig. 3). A hydrophobic stacking
Fig. 4. Electron-density maps drawn in
O [29]. (a) The 2Fo-Fc map of the wild-
type ERK2 around the lip calculated
with data from 6-2.3 A contoured at
1.25cr. (b) T183E difference map com-
puted with (IFomutantl-lFowild-typel) co-
efficients from 20-2.3 A and native
model-derived phases (a) contoured at
2.5a. Positive density is shown in blue.
Negative density is shown in brown.
(c) The (IFo(mutant)l-lFo(wild-type)l T183E/
Y185E contoured at -2.5r. (d) The
2Fo-Fc map of T183E/Y185E computed
with refined phases and contoured at
1.25cr.
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interaction clusters R170, K201 and Y203 (Figs 2,3) at the
center, and the lip is wrapped around the outside, reminis-
cent of an Q-loop. There are two connecting hydrogen
bonds (D1770-K201N and D177081-Y203N). In
ERK2, the guanidinium group of R146 also forms two
hydrogen bonds to the backbone of loop199-205. Inter-
estingly, the residues that form the hydrophobic stack are
also conserved in several other kinases, including cAPK.
However, in cAPK the interactions at this site are quite
different: Y215(203) forms an electrostatic interaction
with R165(146) (similar to Y185 in ERK2, see below)
and K213(201) faces the solvent. With R146 in close
proximity, three positively charged residues are clustered.
Two of these, R146 and R170, contribute to the con-
served phosphate-binding site identified in cAPK. The
sequences of the lip and loop199-205 are linked by the
P+1 specificity pocket (residuesT188-R192) and a six-
residue a-helix (A193-L198) (labeled ao2L12, in Fig. la).
The lip also makes contacts with the remainder of the
structure. Y185 is the focus of a hydrophobic patch where
one face of the phenyl ring makes extensive contacts with
R192 (in the P+1 specificity pocket) and I196 in ox2L12
(Fig. 3). The opposite face of the phenyl ring makes loose
contacts with A187 and G202, while Y1850q is close to
R146Nql (3.5 A). Another hydrophobic patch centers
around F181 and L182. These residues lie in a surface
depression consisting of L198 in a2L12, L232 in the G-
helix, and A258 and Y261 in a2L14 a-helix that is part of
a large insertion in ERK2 relative to cAPK (Fig. 3).
Hydrogen bonds and ion pairs are also present within the
lip and connect the lip to the surrounding structure. Inter-
nal to the lip, hydrogen bonds link T1790y and G180N,
T1830y and G1800, and D173081,2 and H176N81.
Two bonds link the lip to loopl99-205, as described
above. Three other hydrogen bonds link A1870 and
R192Nr1l (in the P+1 specificity pocket), F181N and
N255081 (in the L14 insertion), and E1840 and
Y2310'T (at the N terminus of the G-helix). H178NB1
forms a hydrogen bond with T1570 of a neighboring
molecule in the crystal lattice. In total, 11 hydrogen bonds
stabilize the low-activity conformation of the lip.
Enzymatic properties of mutant ERK2 molecules
ERK2 mutants with altered phosphorylation sites were
synthesized to ascertain the role of these residues in acti-
vation. Single-residue mutations in the phosphorylation
sites of ERK2 have little effect on the basal activity,
although they do interfere with the activation of ERK2
by phosphorylation. In a previously published study [10],
the tyrosine phosphorylation site was removed from
ERK2 by replacing Y185 by phenylalanine. This mutant
enzyme could no longer be activated above the basal level.
Also, a glutamate was substituted at position 183 to mimic
the effect of phosphothreonine. T183E was demonstrated
to be phosphorylated on Y185 and activated to 10% of
the wild-type levels (Table 1). Additional mutants were
synthesized to ascertain whether a constitutively active
ERK2 could be synthesized by introducing glutamate
residues at the phosphorylation sites in Y185E and the
double mutant T183E/Y185E. A second double mutant
T183E/Y185G was made to determine whether Y185
has any role other than to sterically inhibit the enzyme in
the low-activity structure, as suggested previously [15].
None of these mutants has enhanced basal activity.
Y185E, which retains a phosphorylation site, can be
phosphorylated by MEK (-0.4 mol mol-l) and weakly
activated (Table 2). The double mutants have only basal
levels of activity.
Taken together, these data show that glutamate at posi-
tion 183 can partially substitute for phosphothreonine in
the active structure, when Y185 is phosphorylated.
However, glutamate at position 185 can substitute only
Table 1. Activity of wild-type and mutant ERK2 before and after
phosphorylation with MEK kinase.








Table 2. Statistics of data collection, scaling and refinement.
Crystal Native T183E Y185E Y185F Y185E/183E
Data
Resolution (A) 2.3 2.3 2.7 3.5 2.5
Reflections measured 62796 37906 27790 20251 22412
Unique reflections 17755 15258 10203 4408 12035
Completeness (%) 99 85 92 90 85
Rsyma (%) 5.1 2.5 4.43 4.8 5.18
Refinement
Resolutions (A) 6-2.3 6-2.3 6-2.7 6-3.5 6-2.5
Reflections (F/o>2) 15202 13895 8608 3980 11 030
Scale factors 1 0.718 1.831 2.227 0.204
Scale B-factors (A2) 0 0.9 2.5 0 -11.8
Water molecules 80 0 0 0 0
R-factorb 16.4% 19.0% 15.8% 15.2% 17.0%
Free R-factorc(%) 21.5 23.2 23.0 18.8 22.5
Geometry deviations:
Rms bonds (A) 0.010 0.011 0.010 0.010 0.090
Rms angles (°) 1.54 1.61 1.62 1.62 1.63
Rms B-factord (A2) 2.0 1.8 2.5 2.0 2.5
Rms Ca shifte (A) 0.38 0.21 0.26 0.36
aRsym =tlli-<l>l/'li, where li is the intensity of an individual meas-
urement and <I>is the mean value of its equivalent reflections.
bR-factor=gI Fobs -lFcalclI/Z Fobsl, where IFobs and Fcalcl are the
observed and calculated structure-factor amplitudes respectively. CFree
R-factor was calculated using a subset of data (10%) which was excluded
from refinement until the last round. dRms B-factor was calculated for
the main-chain atoms within each residue. eRms Ca shift of the mutants
relative to the wild-type was calculated without the disordered residues
in the wild-type and the disordered lip.
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poorly for phosphotyrosine to form the active structure
when T183 is phosphorylated. Furthermore, because the
double mutant T183E/Y185G has only basal activity,
Y185 may have a role in forming the active structure.
Crystallographic analysis of the mutant enzymes
Crystallization conditions similar to those used for the
native enzyme were effective in producing crystals of the
mutants T183E, Y185F, Y185E, and the double mutant
T183E/Y185E. Data were collected on the mutant
enzymes to a resolution comparable, in most cases, to that
of the native enzyme, 2.3 A. The only exception is Y185F
for which only small crystals that diffracted to 3.5 A could
be obtained. The structures were refined as described in
the Materials and methods. In the wild-type enzyme, the
lip and surrounding structure are well defined in the elec-
tron-density map (Fig. 4a), with the exception of residues
L182, E184 and V186 as noted above.
The mutant T1 83E
The differences between the mutant and wild-type
enzyme are observed in the difference map (Fig. 4b)
computed as described in the legend to Fig. 4. In the
final refined model, few structural changes are observed.
Disorder is introduced in residues E183 and A187 by the
mutation. As noted above, residues that flank the phos-
phorylation sites are disordered in the wild-type enzyme;
thus, in this mutant the electron density is weak from
E183-A187 (Table 3). Y185, however, remains fixed.
Hydrogen bonds between T1830y and G180N and
between A1870 and R192Nx1 are lost, apparently as a
consequence of the disorder introduced. The overall root
mean square (rms) shifts of Ca atoms, calculated for
residues that do not become disordered, are -0.25 A
(Table 2), which is no larger than the coordinate error.
Thus, it is possible to conclude that T183 makes a small
contribution to the stability of the low-activity con-
formation of ERK2, and introduction of a charge at
position 183 may disrupt this structure slightly.
The mutants Y185E and T183E/Y185E
The structures of two mutant enzymes containing a
glutamate at position 185 were determined, Y185E and
the double mutant T183E/Y185E containing a gluta-
mate at both positions 183 and 185. The difference map
for both of these mutants (Fig. 4c) shows negative den-
sity throughout the entire lip (residues D173-A187) and
in loop199-205 between residues S200 and Y203
(Table 3; Fig. 4c). In the double mutant, the difference
map of which is shown in Fig. 4c, the negative density
is more pronounced than in the single mutant, and
includes N251-I254 in aolL14 and E58-C63 near the
N terminus of helix C. The disorder is also apparent
from the refined electron-density map (Fig. 4d). The
density is broken and weak around the lip, whereas
neighboring residues such as R146 and D147 (Fig. 4d)
are well defined. The residues that become disordered
are summarized in Table 3. In mutant Y185E,. 19
residues are disordered in the lip and loopl99-205. The
carboxylate of E185 is weakly visible in the Y185E
mutant but not in the double mutant T183E/Y185E.
The side chain of F181, which resides in one of the
hydrophobic patches, is weakly observed, despite disor-
der in its main chain. However, K201, Y203 and the
side chain of R170 in the hydrophobic stack are disor-
dered, and their interactions with the lip are lost. Also,
all of the hydrogen bonds internal to the lip, and
between the lip and the rest of the molecule, are lost in
the mutants containing a glutamate at position 185. The
interactions that are lost are those between D1770 and
K202N, D177081 and Y203N, F181N and N255081,
E1840 and Y2310Or, A1870 and R192Nrql, and
between R146NE1 and K2010 and G2020. The
residues that are linked by a hydrogen bond to the lip in
the native structure are shifted or disordered in the
mutant enzymes. For example, the guanidinium groups
of R146 and R192 are displaced by ~1.0 A, but remain
ordered in both Y185E and T183E/Y185E. In contrast,
the side chain of Y231 becomes disordered. The lattice
contact formed by H178 in the lip is lost.
Although the structural basis for the low stability is
uncertain, it may be due to the unusual cluster of three
positively charged amino acids R146, R170, and K201.
As noted above, these cluster at the core of the inter-
action between the lip and loop199-205 (Fig. 3), and
although the residues involved are conserved between
ERK2 and cAPK, the nature of the interaction is
completely different in the two molecules.
The B-factors of the main-chain atoms of native ERK2
are shown in Fig. 5a. The B-factors in the wild-type
enzyme are elevated at the termini of the molecule and
in a few other loops (Fig. 5a). The shift in B-factors in
the mutants is shown in Fig. 5b. The B-factors in T183E
are elevated in the lip (173-188), and loop199-205, as
discussed below. The B-factors in the double mutant are
elevated in two other regions, centered around
N251-1254 and E58-C63. The data set for T183/Y185
Table 3. Disorder in ERK2 mutants.
Mutant Location Disordered residues
Wild-type main chain V186
side chain L182, E184,V186
T183E main chain E183,V186, A187
side chain L182, E184, El 83,V186, A187
Y185E main chain Dl 73-Al 87,S200-Y203
side chain D173-Gl 80, Ll 82-Al 87, S202-Y203,Y231
T183E/ main chain D173-A187, S202-Y203, E58-C53, N251-1254
Y185E side chain D1 73-Gl 80, L 182-Al 87, S202-Y203,Y231,
E58-C53, N251-1254
Y185F main chain D173-A187, E58-C53
side chain Dl 73-G180, L182-El 84,V186-Al 87, E58-C53
Named residues have B-factors in excess of 50A2 for T183E, Y185E and
Tl 83/Y185E.
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(a)
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Fig. 5. (a) Plot of B-factors (temperature factors in A) of the main-
chain atoms as a function of sequence of the wild-type ERK2.
The average B-factor of ordered main-chain atoms is 29.8 A2.
The average B-factor of the main-chain atoms from residues
63-327 is 24.5 A2, from residues 17-62 and from residues
328-358 is 52.9 A2. (b) Plot of shifts in B-factor of main-chain
atoms in ERK2 mutants relative to wild-type. In T183E/Y185E, the
B-factor shifts for the indicated residues were as follows: residues
58-63 over 35 A2, 173-187 over 45 A2, 197-203 over 30 A2,
and 248-254 over 25 A2. In T183E, the lip region has B-factor
shifts over 30 A2, and residues 198-203 over 20 A2.
gives a relatively large scaling B-factor (Table 2), suggest-
ing that there is some general disorder in the crystal of
this double mutant. However, the changes in B-factor
local to the lip are independent of the scaling method.
Mutant Y185F
Like Y185E, Y185F has negative density on the phos-
phorylation lip in the difference map (data not shown).
Although, the resolution of the Y185F data is limited,
it is possible to carry out a partial refinement using
Powell minimization in X-PLOR. The refined model
from this analysis reveals disorder throughout the phos-
phorylation lip. However, the level of disorder is less than
in the other Y185 mutants, with an average shift in the
B-factor of 15 A2. The disorder does not extend to
loopl99-205. F185 occupies a position similar to Y185
in the wild-type enzyme, but is found shifted away from
R146. This displacement could be due to loss of the
favorable electrostatic interaction between Y1850q and
R146Nqll. From the disorder in this mutant we can
conclude that the loss of a single atom, the hydroxyl
oxygen of Y185, disrupts the structure of the lip.
B-factor shifts
When the shifts in B-factors for all of the mutants are
compared (Fig. 5b), it is apparent that the B-factor shifts
for each mutant occur in the same parts of the molecule.
Thus, whereas Y185E exhibits the largest changes for a
point mutation, the other three mutants cause correlated
changes. The correlated nature of the B-factor shifts in
the different mutants shows that the flexibility is a prop-
erty of the molecule and not due to the specific amino
acid replacement.
Interestingly, the T183E/Y185E double mutant shows
disorder in two sequences distant from the lip. One
region is unique to the ERK family (N251-I254) and
the other lies near the N terminus of helix C, where the
structure of ERK2 diverges significantly from that of
cAPK and cyclin dependent kinase 2 (CDK2). There-
fore, it is expected that these regions are important for
either substrate specificity or regulation of ERK2.
Region N251-I254 (in otlL14) interacts with the lip, but
helix C does not contact the lip, so that the origin of the
disorder in E58-C63 is unclear. It may be that this disor-
der and the slight elevation of the B-factors in the double
mutant is a consequence of lattice contact losses, as 1254
is involved in a lattice contact. The negative B-factor
shifts in Y185E near the N and C termini are probably
insignificant, and due to the large B-factors in the wild-
type enzyme in these areas of the structure (Fig. 5a).
Putative binding site for both phosphotyrosine and
phosphothreonine
ERK2 may have two phosphate-binding sites to accom-
modate the two phosphorylated residues in the active
enzyme. One likely binding site, which appears to be
conserved among many serine/threonine-specific
kinases, consists of residues R146 and R170 (see above)
and R65 in helix C in ERK2 [15,17,19]. This phos-
phate-binding site is also conserved in the kinase ERK3.
ERK3 has a threonine at position 183 but a glycine at
position 185. Therefore, T183-PO 4 is likely to bind to
the conserved site. A significant rearrangement of the lip
is required to obtain this interaction, because in the low-
activity structure T183 is -9 A from R146. This binding
interaction may promote domain rotation in ERK2 to
create a closed catalytic site similar to that found in cAPK
[15]. For the conserved R146 to bind to a phosphate ion,
it must lose its interactions with the backbone of
loopl99-205. It is interesting that these interactions are
indeed lost in two of the mutants described above.
ERK2 has a second cluster of positively charged residues
near the phosphorylation lip. This cluster consists of
R189 and R192, and is not conserved in other kinases.
Further refinement of the wild-type crystal structure car-
ried out in this study, revealed a sulfate ion, present in the
crystallization buffer, in contact with R189 and R192
(Figs 2,3). These residues are close to Y185, in the P+1
mkue nuber
ride u..ber
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specificity pocket identified in cAPK [20]. Although the
primary function of Y185 appears to be in securing the
low-activity conformation, Y185-PO 4 may play a role in
the active conformation. Biochemical evidence for this
suggestion can be derived from the low activity of the
double mutant T183E/Y185G: if Y185 were acting
solely to secure the inactive conformation by binding in
its inhibitory site, then removing its side chain might
have been expected to create a constitutively active
enzyme in T183E/Y185G. However, this is not the case.
Therefore, these two arginines may serve as the second
phosphate-binding site in the active conformation of
ERK2, and bind to Y185-PO 4.
Discussion
The phosphoregulation of protein kinases is highly
unusual. Many of the phosphorylation sites reside in a
single loop at the mouth of the catalytic site. In ERK2,
Y185 phosphorylation is kinetically favored, even though
the residue is buried within the structure. Both of the
phosphorylation-site residues are out of alignment with
potential phosphate-binding ligands on the surface of the
enzyme. Consequently, several mechanistic questions
arise: first, how do the phosphorylation-site residues
become available for phosphorylation; second, what are
the roles of the individual phosphorylation sites in the
activation mechanism; and finally, how much of the
structure is involved in the conformational changes asso-
ciated with activation? Furthermore, several general
questions arise concerning the way in which different
mechanisms of regulation are accommodated in this
region and by which the active sites of associated kinases
and phosphatases co-evolve. The remarkable degree of
disorder observed when Y185 is mutated lends insights
into many of these questions.
The disorder observed in the mutant ERK2 enzymes
studied here, shows that the stability of the lip region is
rather low. Changes such as point mutations, or intro-
duction of buried charges, do not ordinarily lead to sig-
nificant loss of structure [21]. As the stability is low, it is
expected that only modest amounts of binding energy,
supplied by the activating enzyme, are required to dis-
lodge Y185 for phosphorylation. The preferential phos-
phorylation of Y185 may simply result from a more
favorable interaction when Y185 is bound in the active
site of MEK. The disorder throughout the lip region also
suggests that the entire lip changes conformation when
bound to the activating enzyme. Interestingly, a modeling
study of known tryptic cleavage sites in proteins of
known structure shows that at least 12 residues must
change conformation for the cleavage site to fit into the
trypsin active site [22]. Modeling shows that a similar
number of conformational changes are required to allow
binding of the lip of ERK2 to the active site of MEK.
The disorder observed in Y185 mutants but not in T183
mutants provides information about the roles of these
residues in activation. Y185 has a primary function in
securing the inactive conformation of the enzyme: muta-
tion of Y185 to a glutamate or phenylalanine causes
extensive disorder. Because the conformational changes
and disorder associated with the replacement of T183 are
much less pronounced than those in Y185 mutants, it
seems that T183 is less important in the low-activity
structure. On the other hand, both residues once phos-
phorylated may participate in the active conformation,
and two putative sites for binding of phosphothreonine
183 and phosphotyrosine 185 have been identified.
Local refolding appears to be required to bring either of
the phosphorylation-site residues into alignment with the
conserved phosphate binding site observed in cAPK [18],
or with the putative phosphate-binding site described
above. It is interesting in this regard that introducing a
negative charge at position 185 induces extensive disor-
der, suggesting that the low-activity conformation is
inconsistent with a charge at this position. Refolding is
apparently also required in CDK2 to bring T161 into
alignment with the conserved phosphate-binding site
[17]. It may be that refolding is involved in the activation
of other kinases as well. This mechanism, involving
refolding of a surface loop, is distinct from that observed
in isocitrate dehydrogenase, which is also phosphorylated
near the atalytic site [23]. However, refolding is rem-
iniscent of the order-disorder transition observed in
other active sites, for example, that of triose phosphate
isomerase [24].
Biological implications
Many protein kinases are regulated by phosphory-
lation that takes place within a short region of
their polypeptide sequence, known as the lip,
which is near the active site. In any one molecule,
the lip must assume at least four different confor-
mations - the inactive and active structures, and
the structures as bound to their activating and
deactivating enzymes. Although no structural data
are yet available for unphosphorylated and phos-
phorylated forms of the same enzyme, compari-
son of the available kinase structural data suggests
that the lip is likely to be folded differently in the
active and inactive structures. Extracellular signal-
regulated kinase 2 (ERK2) is a very tightly regu-
lated kinase in the ras-activated protein kinase
cascade and has two phosphorylation sites within
the phosphorylation lip, a tyrosine and a threonine.
Phosphorylation by the MAP/ERK kinase (MEK),
occurs first on the tyrosine residue that is buried in
the unphosphorylated enzyme, but phosphoryla-
tion of the threonine residue is also required to
produce the active enzyme.
We mutated the tyrosine and threonine phosphory-
lation-site residues to glutamate and phenylalanine
to study the role of each site in activation. None
of the mutants produced a constitutively active
enzyme, in the absence of phosphorylation at the
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second site. This is consistent with the fact that no
oncogene derived from the ERK2 gene has been
observed. The crystallographic analysis described
here reveals that the entire lip is disordered when
certain point mutations are introduced within the
regulatory sequence. This shows that the stability
of the 19-residue lip is low, and provides further
evidence for the theory that the lip may be
refolded in the active structure. This low stability
may be an important factor in the binding of the
lip region of ERK2 to kinases and phosphatases,
and helps to explain the fact that the phosphoryla-
tion of the buried tyrosine is kinetially favored.
Regulatory sequences that occur in the termini of
other molecules are known to undergo order/dis-
order transitions [25]. Surprisingly, however, the
protein kinases the flexible regulatory sequence is
internal to the polypeptide chain. The close prox-
imity of the phosphorylation lip to the active site
may facilitate the tight regulation observed in the
MAP kinases - regulation that is acheived without
additional regulatory sequences or subunits.
Materials and methods
Expression, assay, and mutagenesis
ERK2 and mutants were expressed in Escherichia coli using the
expression vector NpT7-5 with an incorporated hexahistidine
tag to aid purification. Point mutations were introduced into
ERK2 as described in [10]. Assay of basal kinase activity towards
myelin basic protein (MBP) was carried out using
0.01 ptg ml-1 ERK2, 0.3 mg ml- ' MBP, and 100 M ATP
([y 32P]ATP, 1-10 cpmf mol-1) in 5 mM HEPES buffer pH 8.0,
10 mM -glycerol phosphate, and 0.2 mg ml- ' bovine serum
albumin at 300 C for 1 h. ERK2 was activated by incubation
with MEK1 (50 ltg ml-t ). The MEKI, in turn, was activated
with the catalytic domain of MEK kinase (Xu, S.C. et al.,
unpublished data). The specific activity of activated ERK2 was
determined as above, at an ERK2 concentration of 0.2 mg ml-'-
Crystallization, data collection, and scaling
Recombinant ERK2 mutant molecules were expressed,
purified and crystallized as described in [26]. All of the mutants
that crystallized did so in the same space group as the wild-type
enzyme, P21, with similar cell constants. Data for Y185F,
T183E and Y185E were recorded using Xuong-Hamlin area
detectors in 0.10 frames and X-rays generated on an Rigaku
RU200 rotating anode source operated at 50 kV, 100mA. Data
for the double mutant T183E/Y185E were collected using
R-axis II imaging plates in 2 oscillations. Data sets for the
mutant enzymes were scaled to the wild-type data set so that
the individual atomic B-factors were on a common scale. Scal-
ing was carried out in PROTEIN [27]. The B-factors were
obtained from refinement using the mutant data that were
scaled individually with the wild-type in PROTEIN [27]. Data
statistics and scale factors are summarized in Table 2.
Refinement
The model reported in [15] was further refined at 2.3 A
(Table 2). The present model of the wild-type enzyme includes
80 water molecules and one sulfate ion. The wild-type model
was used as a starting point for refinement of the mutants.
The water molecules were omitted. Powell minimization was
carried out in X-PLOR [28] for all of the mutants. T183E,
Y185E and T183E/Y185E were further refined using molecu-
lar dynamics simulation with an initial temperature of 1000 K.
Individual atomic B-factors were refined using restraints of
1.5cr for main-chain atoms and 2.0cr for side-chain atoms. After
each cycle, the model was fitted to a 2 Fobs - Fcalc I map cal-
culated with refined phases in programs O [29] or FRODO
[30]. Only one cycle of Powell minimization and temperature-
factor refinement was carried out for Y185F because of the lack
of data. In the final model of the native enzyme, residues 2-16,
29-34, 330-336 and 355-358 have weak density and are disor-
dered. All of the peptide torsion angles of the native and
mutant models fall within the most favored regions or addi-
tional allowed regions of the Ramachandran (,M') diagram as
defined in [31], except for R146. This residue has been
checked by modeling, and appears to be correct. Stereochemi-
cal parameters measured in PROCHECK [32], were found to
have better than 'ideal' values [33]. These stereochemical para-
meters include: percentage of residues in the most favorable
regions of the Ramachandran diagram, number of close con-
tacts, hydrogen bond energy, and the standard deviations of
various torsion angles, co, z, X1 and X2 .
The coordinates will be deposited in the Brookhaven Protein
Data Bank.
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